This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vulvodynia Treatment Market

Market Insights on Vulvodynia Treatment covering sales outlook, demand forecast & up-to-date key trends

Vulvodynia Treatment Market by Drug Class (Local Anesthetics, Anticonvulsant, Tricyclic Antidepressants, Hormones, Serotonin-norepinephrine Reuptake Inhibitors (SNRIs), Nerve Blocks), Mode of Application (Oral, Topical, Injection) & Region for 2022-2028

Vulvodynia Treatment Market Outlook (2022-2028)

[246 Pages Report] Revenue from the global Vulvodynia Treatment Market is currently valued at US$ 5.6 Bn, and is projected to top US$ 8 Bn by 2028, increasing at an impressive CAGR of 6.3% over the period of 2022 to 2028.

Global Vulvodynia Treatment Market Size (2022)

US$ 5.6 Bn

Revenue Forecast (2028)

US$ 8 Bn

Global Market Growth Rate (2022-2028)

6.3% CAGR

North America Market Share

30.2%

Vulvodynia treatment currently accounts for 73.4% share of the global neuropathic pain market, with North America and Western Europe leading the way as far as demand is concerned.

Customize this Report

Let us know your requirement to get
100% FREE customization

Vulvodynia Treatment Demand Analysis (2013 to 2021) Vs Market Outlook (2022 to 2028)

Vulvodynia is an unexplained, complex cause of chronic vulvar pain or discomfort that can affect women of all ages and in any reproductive phase. The disease's complicated genesis as well as the symptoms of concomitant pain syndrome make illness management challenging.

Vulvodynia pain has a bad impact on sexual health as well reproductive health. Although the symptoms of vulvodynia aren't life-threatening, they can nonetheless have a significant influence on one’s life. Physiology, emotions, experiences, beliefs, lifestyles, and relationships all have a role in sexual response. Any component that is disrupted can have an impact on sexual and reproductive health.

Vulvodynia treatment demand rose at a CAGR of 5.2% from 2013 to 2021. Several therapies have come about in recent years that aim to address the biological, psychological, and interpersonal variables that contribute to this illness. This is a critical aspect driving consistent growth of the global vulvodynia therapy market.

Vulvodynia Treatment Market Download Report Brochure

Better diagnostic techniques and disease models have increased our understanding of the disease phenotype, propelling the vulvodynia therapeutic industry forward. Vulvodynia treatment demand is predicted to increase at a high CAGR of 6.3% from 2022 to 2028, with the global market expected to cross a valuation of US8 Bn by 2028.

Vulvodynia treatment at home has been performed since ages, where antidepressants and anticonvulsants have raised to the top of the list of vulvodynia therapy options. Vulvodynia treatment at home can help reduce pain to some extent. Individuals may need to attempt a variety of vulvodynia treatment at home before determining which ones are the most effective. It is also notable that vulvodynia treatment over the counter can be risky and one should consult doctor beforehand.

Which Factors are Expected to Drive Vulvodynia Treatment Market Growth?

“Anaesthetic Gels & Creams and Appropriate Diet Options Driving Market Growth”

Growing economic and social impact of vulvodynia is driving demand for vulvodynia therapies in different regions of the world. Rising awareness of the impact of vulvodynia on the healthcare systems in developed nations is also propelling the industry forward.

Growing knowledge of vulvodynia diagnostics among clinicians, particularly gynaecologists, is propelling the worldwide vulvodynia therapy market ahead. Advances in various therapeutic methods for vulvodynia management are projected to open up new opportunities for market players.

The industry's focus on multidisciplinary approaches to disease management has a positive impact on market prospects. A key trend driving vulvodynia demand growth is the increased acceptability of local anaesthetics in the form of gels or creams to reduce pain-related discomfort in the patient populations.

A good example is the increased demand for lidocaine gel or cream. Increased research on expanding first-line vulvodynia treatment is also fuelling the market's steady growth. It is also important not to repeatedly make use of over-the-counter vulvodynia treatment options without consulting a doctor.

The market will benefit from relentless research and development initiatives targeted at discovering a reliable therapeutic strategy for controlling vulvodynia. Unmet needs in vulvodynia therapy are likely to be addressed by the expanding number of psychophysical research programs.

A recent study shows that vulvodynia treatment diet plays an important role, and keeping patients on a particular diet can help recover from vulvodynia pain. Dieticians are now researching on particular vulvodynia treatment diets to lessen the discomfort.

Female sexual dysfunction has become a common problem worldwide, and can strike at any age. Female sexual dysfunction treatment performed under the guidance of a specialist can help overcome pain. Education and information on sexual health is also helping in raising awareness of female sexual dysfunction treatment across regions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Regional Markets are Set to Be Lucrative for Vulvodynia Treatment Providers?

“North America Handsomely Leading Global Vulvodynia Treatment Market”

These vulvodynia treatment market insights shed light on regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA). 

The North America vulvodynia treatment market is expected to account for the highest market share of around 30.2% in the global landscape in 2022. A recent Harvard study showed that there are approximately 6 Mn American women who are suffering from vulvodynia. 

The vulvodynia treatment devices market in Western Europe and Eastern Europe are expected to be driven by rising popularity of vulvodynia treatment procedures, increasing medical research & development, etc. The Western Europe and Eastern Europe market together are set to account for 30.6% of the global market share in 2022.

The Latin America vulvodynia treatment market is set account for 10.1% of the global market share in 2022. APEJ is expected to be the third-most lucrative market with 19.6% market share in 2022. This is because of rapidly increasing penetration of generics in China and India.

The vulvodynia treatment equipment market in the MEA region is expected to progress at a slightly slower rate than other regions, but this trend is anticipated to change by the end of the forecast period. In 2022, the market in MEA is set to account for 3.2% of the global market share.

Country-wise Analysis

How is Demand for Vulvodynia Treatment Expected to Shape Up in the U.S.?

 “Well-established Healthcare Infra in the U.S. Driving Vulvodynia Treatment”

The United States is one of the top countries driving vulvodynia treatment demand. The country's prospects are being boosted by the presence of well-developed healthcare infrastructure and the availability of skilled medical staff.

Throughout the projected period, the United States market is expected to grow at a robust rate. The country is boosting its spending on biopharmaceutical research and development in order to develop cures for uncommon diseases, which bodes well for vulvodynia treatment system providers in the country.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Analysis

Which Vulvodynia Treatment Drug is Set to Gain Immense Popularity?

“Anticonvulsants Most Prescribed Vulvodynia Treatment Drugs”

Anticonvulsants are medications that are used to prevent seizures or stop a series of seizures from occurring (convulsions). Anticonvulsants are the most commonly prescribed medications for vulvodynia treatment.

Gabapentin is the most effective anticonvulsant medicine for the treatment of vulvodynia. Gabapentin is a medicine that has long been known as an excellent pain reliever in chronic pain management. It consists of tablets that are taken orally and are effective for nerve pain relief. These tablets are used to treat a variety of disorders that affect the central nervous system, as well as discomfort in the spinal cord. Another anticonvulsant is pregabalin. It's quite similar to gabapentin, but it's said to have fewer side effects and believed to be more effective.

Tricyclic antidepressants (TCAs) are a type of drug that are primarily used to treat depression. A doctor can prescribe them in lesser amounts than those used to treat depression. These medications are given because they change the way nerve fibres convey pain signals.

COVID-19 Impact on Market

Over the period of 2020 and 2021, the COVID-19 pandemic had a deleterious impact on most medical procedures. People were unable to visit hospitals for various medical treatments and procedures due to COVID-19 pandemic restrictions. The vulvodynia treatment market also saw a decrease in demand, as focus of the healthcare sector was mainly on COVID.

Also, due to supply chain disruptions, there was a shortage of the equipment, drugs, and materials needed to undertake successful vulvodynia treatment procedures. However, the global vulvodynia treatment market is recovering as respective government agencies have lifted most enforced lockdowns and restrictions.

Competitive Landscape

Companies are looking for therapies and medications that might alleviate the discomfort associated with vulvodynia in order to meet the demand of an increasing number of patients. They are spending more on research and development as well as mergers and acquisitions to achieve this. As a result, this will help them increase their target bases by being able to cater to both, global and domestic audiences.

Eli Lilly and Company, AstraZeneca Plc., GlaxoSmithKline Plc., Pfizer Inc., Johnson & Johnson Services, Inc., and Allergan plc are among the major vulvodynia treatment equipment manufacturers.

Vulvodynia Treatment Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Drug Class
  • Mode of Administration
  • Distribution Channel
  • Region

Key Companies Profiled

  • Eli Lilly and Company
  • AstraZeneca Plc.
  • GlaxoSmithKline Plc.
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Allergan plc

Pricing

Available upon Request

Key Segments of Vulvodynia Treatment Industry Survey

Vulvodynia Treatment Market by Drug Class:

  • Local Anesthetics
  • Anticonvulsant
  • Tricyclic Antidepressants
  • Hormones
  • Serotonin-norepinephrine Reuptake Inhibitors (SNRIs)
  • Nerve Blocks
  • Others

 Vulvodynia Treatment Market by Mode of Application:

  • Oral Vulvodynia Treatment
  • Topical Vulvodynia Treatment
  • Injection Vulvodynia Treatment

 Vulvodynia Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Online Pharmacies

 Vulvodynia Treatment Market by Region:

  • North America Vulvodynia Treatment Market
  • Latin America Vulvodynia Treatment Market
  • Europe Vulvodynia Treatment Market
  • East Asia Vulvodynia Treatment Market
  • South Asia & Pacific Vulvodynia Treatment Market
  • Middle East & Africa (MEA) Vulvodynia Treatment Market

Frequently Asked Questions

The global vulvodynia treatment market is estimated to surge at a CAGR of 6.3% through 2028.

The global market for vulvodynia treatment is currently worth US$ 5.6 Bn.

Key vulvodynia treatment product providers are Eli Lilly and Company, AstraZeneca Plc., GlaxoSmithKline Plc., Pfizer Inc., Johnson & Johnson Services, Inc., and Allergan.

The global vulvodynia treatment market is anticipated to cross a valuation of US$ 8 Bn by 2028.

The Japan vulvodynia treatment market currently holds 6.3% share in the global market.

Table of Content

1. Executive Summary

  1.1. Market Overview

  1.2. Market Analysis

  1.3. FMI Analysis and Recommendations

  1.4. Wheel of Fortune

2. Market Introduction

  2.1. Market Taxonomy

  2.2. Market Definition

3. Vulvodynia Treatment Market View Point

  3.1. Macro-Economic Factors

  3.2. Opportunity Analysis

  3.3. Occurrence of Vulvodynia

  3.4. Regulatory Scenario

4. Vulvodynia Treatment Market Dynamics

  4.1. Drivers

  4.2. Restraints

  4.3. Opportunities

  4.4. Trends

5. North America Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  5.1. Introduction

  5.2. Regional Market Dynamics

  5.3. Historical Market Size (US$ Mn) By Country, 2013-2021

    5.3.1. U.S.

    5.3.2. Canada

  5.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

    5.4.1. U.S.

    5.4.2. Canada

  5.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    5.5.1. Anticonvulsant

    5.5.2. Tricyclic Antidepressant

    5.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    5.5.4. Hormone

    5.5.5. Nerve Block

    5.5.6. Local Anesthetic

    5.5.7. Others

  5.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    5.6.1. Anticonvulsant

    5.6.2. Tricyclic Antidepressant

    5.6.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    5.6.4. Hormone

    5.6.5. Nerve Block

    5.6.6. Local Anesthetic

    5.6.7. Others

  5.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    5.7.1. Oral

    5.7.2. Topical

    5.7.3. Injectable

  5.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    5.8.1. Oral

    5.8.2. Topical

    5.8.3. Injectable

  5.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    5.9.1. Hospital Pharmacies

    5.9.2. Retail Pharmacies

    5.9.3. Drug Stores

    5.9.4. Online Pharmacies

  5.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    5.10.1. Hospital Pharmacies

    5.10.2. Retail Pharmacies

    5.10.3. Drug Stores

    5.10.4. Online Pharmacies

  5.11. Drivers and Restraints: Impact Analysis

  5.12. Market Attractiveness Analysis

    5.12.1. By Country

    5.12.2. By Drug Class

    5.12.3. By Mode Of Administration

    5.12.4. By Distribution Channel

  5.13. Key Representative Market Participants

  5.14. Key Participants Market Presence (Intensity Map)

6. Latin America Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  6.1. Introduction

  6.2. Regional Market Dynamics

  6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2021

    6.3.1. Brazil

    6.3.2. Mexico

    6.3.3. Rest of Latin America

  6.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

    6.4.1. Brazil

    6.4.2. Mexico

    6.4.3. Rest of Latin America

  6.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    6.5.1. Anticonvulsant

    6.5.2. Tricyclic Antidepressant

    6.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    6.5.4. Hormone

    6.5.5. Nerve Block

    6.5.6. Local Anesthetic

    6.5.7. Others

  6.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    6.6.1. Anticonvulsant

    6.6.2. Tricyclic Antidepressant

    6.6.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    6.6.4. Hormone

    6.6.5. Nerve Block

    6.6.6. Local Anesthetic

    6.6.7. Others

  6.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    6.7.1. Oral

    6.7.2. Topical

    6.7.3. Injectable

  6.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    6.8.1. Oral

    6.8.2. Topical

    6.8.3. Injectable

  6.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    6.9.1. Hospital Pharmacies

    6.9.2. Retail Pharmacies

    6.9.3. Drug Stores

    6.9.4. Online Pharmacies

  6.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    6.10.1. Hospital Pharmacies

    6.10.2. Retail Pharmacies

    6.10.3. Drug Stores

    6.10.4. Online Pharmacies

  6.11. Drivers and Restraints: Impact Analysis

  6.12. Market Attractiveness Analysis

    6.12.1. By Country

    6.12.2. By Drug Class

    6.12.3. By Mode Of Administration

    6.12.4. By Distribution Channel

  6.13. Key Representative Market Participants

  6.14. Key Participants Market Presence (Intensity Map)

7. Western Europe Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  7.1. Introduction

  7.2. Regional Market Dynamics

  7.3. Historical Market Size (US$ Mn) By Country, 2013-2021

    7.3.1. Germany

    7.3.2. United Kingdom

    7.3.3. France

    7.3.4. Italy

    7.3.5. Spain

    7.3.6. Nordic Region

    7.3.7. Rest of Western Europe

  7.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

    7.4.1. Germany

    7.4.2. United Kingdom

    7.4.3. France

    7.4.4. Italy

    7.4.5. Spain

    7.4.6. Nordic Region

    7.4.7. Rest of Western Europe

  7.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    7.5.1. Anticonvulsant

    7.5.2. Tricyclic Antidepressant

    7.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    7.5.4. Hormone

    7.5.5. Nerve Block

    7.5.6. Local Anesthetic

    7.5.7. Others

  7.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    7.6.1. Anticonvulsant

    7.6.2. Tricyclic Antidepressant

    7.6.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    7.6.4. Hormone

    7.6.5. Nerve Block

    7.6.6. Local Anesthetic

    7.6.7. Others

  7.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    7.7.1. Oral

    7.7.2. Topical

    7.7.3. Injectable

  7.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    7.8.1. Oral

    7.8.2. Topical

    7.8.3. Injectable

  7.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    7.9.1. Hospital Pharmacies

    7.9.2. Retail Pharmacies

    7.9.3. Drug Stores

    7.9.4. Online Pharmacies

  7.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    7.10.1. Hospital Pharmacies

    7.10.2. Retail Pharmacies

    7.10.3. Drug Stores

    7.10.4. Online Pharmacies

  7.11. Drivers and Restraints: Impact Analysis

  7.12. Market Attractiveness Analysis

    7.12.1. By Country

    7.12.2. By Drug Class

    7.12.3. By Mode Of Administration

    7.12.4. By Distribution Channel

  7.13.Key Representative Market Participants

  7.14.Key Participants Market Presence (Intensity Map)

8. Eastern Europe Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  8.1. Introduction

  8.2. Regional Market Dynamics

  8.3. Historical Market Size (US$ Mn) By Country, 2013-2021

    8.3.1. Russia

    8.3.2. Poland

    8.3.3. Rest of Eastern Europe

  8.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

    8.4.1. Russia

    8.4.2. Poland

    8.4.3. Rest of Eastern Europe

  8.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    8.5.1. Anticonvulsant

    8.5.2. Tricyclic Antidepressant

    8.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    8.5.4. Hormone

    8.5.5. Nerve Block

    8.5.6. Local Anesthetic

    8.5.7. Others

  8.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    8.6.1. Anticonvulsant

    8.6.2. Tricyclic Antidepressant

    8.6.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    8.6.4. Hormone

    8.6.5. Nerve Block

    8.6.6. Local Anesthetic

    8.6.7. Others

  8.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    8.7.1. Oral

    8.7.2. Topical

    8.7.3. Injectable

  8.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    8.8.1. Oral

    8.8.2. Topical

    8.8.3. Injectable

  8.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    8.9.1. Hospital Pharmacies

    8.9.2. Retail Pharmacies

    8.9.3. Drug Stores

    8.9.4. Online Pharmacies

  8.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    8.10.1. Hospital Pharmacies

    8.10.2. Retail Pharmacies

    8.10.3. Drug Stores

    8.10.4. Online Pharmacies

  8.11. Drivers and Restraints: Impact Analysis

  8.12. Market Attractiveness Analysis

    8.12.1. By Country

    8.12.2. By Drug Class

    8.12.3. By Mode Of Administration

    8.12.4. By Distribution Channel

  8.13. Key Representative Market Participants

  8.14. Key Participants Market Presence (Intensity Map)

9. Asia Pacific Excluding Japan Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  9.1. Introduction

  9.2. Regional Market Dynamics

  9.3. Historical Market Size (US$ Mn) By Country, 2013-2021

    9.3.1. China

    9.3.2. India

    9.3.3. Australia and New Zealand

    9.3.4. ASEAN

    9.3.5. Rest of APEJ

  9.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

    9.4.1. China

    9.4.2. India

    9.4.3. Australia and New Zealand

    9.4.4. ASEAN

    9.4.5. Rest of APEJ

  9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    9.5.1. Anticonvulsant

    9.5.2. Tricyclic Antidepressant

    9.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    9.5.4. Hormone

    9.5.5. Nerve Block

    9.5.6. Local Anesthetic

    9.5.7. Others

  9.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    9.6.1. Local Anesthetic

    9.6.2. Anticonvulsant

    9.6.3. Tricyclic Antidepressant

    9.6.4. Hormones

    9.6.5. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    9.6.6. Nerve Block

    9.6.7. Others

  9.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    9.7.1. Oral

    9.7.2. Topical

    9.7.3. Injectable

  9.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    9.8.1. Oral

    9.8.2. Topical

    9.8.3. Injectable

  9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    9.9.1. Hospital Pharmacies

    9.9.2. Retail Pharmacies

    9.9.3. Drug Stores

    9.9.4. Online Pharmacies

  9.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    9.10.1. Hospital Pharmacies

    9.10.2. Retail Pharmacies

    9.10.3. Drug Stores

    9.10.4. Online Pharmacies

  9.11. Drivers and Restraints: Impact Analysis

  9.12. Market Attractiveness Analysis

    9.12.1. By Country

    9.12.2. By Drug Class

    9.12.3. By Mode Of Administration

    9.12.4. By Distribution Channel

  9.13. Key Representative Market Participants

  9.14. Key Participants Market Presence (Intensity Map)

10. Japan Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  10.1. Introduction

  10.2. Regional Market Dynamics

  10.3. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    10.3.1. Anticonvulsant

    10.3.2. Tricyclic Antidepressant

    10.3.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    10.3.4. Hormone

    10.3.5. Nerve Block

    10.3.6. Local Anesthetic

    10.3.7. Others

  10.4. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    10.4.1. Anticonvulsant

    10.4.2. Tricyclic Antidepressant

    10.4.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    10.4.4. Hormone

    10.4.5. Nerve Block

    10.4.6. Local Anesthetic

    10.4.7. Others

  10.5. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    10.5.1. Oral

    10.5.2. Topical

    10.5.3. Injectable

  10.6. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    10.6.1. Oral

    10.6.2. Topical

    10.6.3. Injectable

  10.7. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    10.7.1. Hospital Pharmacies

    10.7.2. Retail Pharmacies

    10.7.3. Drug Stores

    10.7.4. Online Pharmacies

  10.8. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    10.8.1. Hospital Pharmacies

    10.8.2. Retail Pharmacies

    10.8.3. Drug Stores

    10.8.4. Online Pharmacies

  10.9. Drivers and Restraints: Impact Analysis

  10.10. Market Attractiveness Analysis

    10.10.1. By Drug Class

    10.10.2. By Mode Of Administration

    10.10.3. By Distribution Channel

  10.11. Key Representative Market Participants

  10.12. Key Participants Market Presence (Intensity Map)

11. Middle East and Africa Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  11.1. Introduction

  11.2. Regional Market Dynamics

    11.2.1. Drivers

    11.2.2. Restraints

    11.2.3. Trends

  11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

    11.3.1. GCC Countries

    11.3.2. South Africa

    11.3.3. Rest of MEA

  11.4. Market Size (US$ Mn) Forecast By Country, , 2022–2028

    11.4.1. GCC Countries

    11.4.2. South Africa

    11.4.3. Rest of MEA

  11.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    11.5.1. Anticonvulsant

    11.5.2. Tricyclic Antidepressant

    11.5.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    11.5.4. Hormone

    11.5.5. Nerve Block

    11.5.6. Local Anesthetic

    11.5.7. Others

  11.6. Market Size (US$ Mn) Forecast and By Drug Class, 2022–2028

    11.6.1. Anticonvulsant

    11.6.2. Tricyclic Antidepressant

    11.6.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    11.6.4. Hormone

    11.6.5. Nerve Block

    11.6.6. Local Anesthetic

    11.6.7. Others

  11.7. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    11.7.1. Oral

    11.7.2. Topical

    11.7.3. Injectable

  11.8. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    11.8.1. Oral

    11.8.2. Topical

    11.8.3. Injectable

  11.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    11.9.1. Hospital Pharmacies

    11.9.2. Retail Pharmacies

    11.9.3. Drug Stores

    11.9.4. Online Pharmacies

  11.10. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    11.10.1. Hospital Pharmacies

    11.10.2. Retail Pharmacies

    11.10.3. Drug Stores

    11.10.4. Online Pharmacies

  11.11. Drivers and Restraints: Impact Analysis

  11.12. Market Attractiveness Analysis

    11.12.1. By Country

    11.12.2. By Drug Class

    11.12.3. By Mode Of Administration

    11.12.4. By Distribution Channel

  11.13. Key Representative Market Participants

  11.14. Key Participants Market Presence (Intensity Map)

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Competition Landscape

  14.1. Competition Dashboard

  14.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

    14.2.1. GlaxoSmithKline plc.

    14.2.2. AstraZeneca Plc.

    14.2.3. Eli Lilly and Company

    14.2.4. Merck & Co., Inc.

    14.2.5. Pfizer Inc.

    14.2.6. Johnson & Johnson Services, Inc.

    14.2.7. Allergan plc.

    14.2.8. Depomed Inc.

    14.2.9. Par pharmaceutical

    14.2.10. Vertical pharmaceutical

15. Global Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Region

  15.1. Introduction / Key Findings

  15.2. Historical Market Size (US$ Mn) Analysis By Region, 2013–2021

    15.2.1. North America

    15.2.2. Western Europe

    15.2.3. Eastern Europe

    15.2.4. Latin America

    15.2.5. Asia Pacific Excluding Japan

    15.2.6. Japan

    15.2.7. Middle East and Africa

  15.3. Market Size (US$ Mn) Forecast By Region, 2022–2028

    15.3.1. North America

    15.3.2. Western Europe

    15.3.3. Eastern Europe

    15.3.4. Latin America

    15.3.5. Asia Pacific Excluding Japan

    15.3.6. Japan

    15.3.7. Middle East and Africa

  15.4. Key Trends / Developments

  15.5. Market Attractiveness Analysis By Region

16. Global Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Drug Class

  16.1. Introduction

  16.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2021

    16.2.1. Anticonvulsant

    16.2.2. Tricyclic Antidepressant

    16.2.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    16.2.4. Hormone

    16.2.5. Nerve Block

    16.2.6. Local Anesthetic

    16.2.7. Others

  16.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    16.3.1. Anticonvulsant

    16.3.2. Tricyclic Antidepressant

    16.3.3. Serotonin-norepinephrine reuptake inhibitors (SNRI)

    16.3.4. Hormone

    16.3.5. Nerve Block

    16.3.6. Local Anesthetic

    16.3.7. Others

  16.4. Market Attractiveness Analysis By Drug Class

17. Global Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Mode Of Administration

  17.1. Introduction

  17.2. Historical Market Size (US$ Mn) Analysis By Mode Of Administration, 2013–2021

    17.2.1. Oral

    17.2.2. Topical

    17.2.3. Injectable

  17.3. Market Size (US$ Mn) and Forecast, By Mode Of Administration, 2022–2028

    17.3.1. Oral

    17.3.2. Topical

    17.3.3. Injectable

  17.4. Market Attractiveness Analysis By Mode Of Administration

18. Global Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Distribution Channel

  18.1. Introduction

  18.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2021

    18.2.1. Hospital Pharmacies

    18.2.2. Retail Pharmacies

    18.2.3. Drug Stores

    18.2.4. Online Pharmacies

  18.3. Market Size (US$ Mn) and Forecast, By Distribution Channel, 2022–2028

    18.3.1. Hospital Pharmacies

    18.3.2. Retail Pharmacies

    18.3.3. Drug Stores

    18.3.4. Online Pharmacies

  18.4. Market Attractive Analysis By Distribution Channel

19. Global Vulvodynia Treatment Market Analysis 2013–2021 and Forecast 2022–2028

  19.1. Market Size and Y-o-Y Growth

  19.2. Absolute $ Opportunity

  19.3. Value Chain

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022-2028  By Country

Table 02: North America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022-2028  By Drug Type

Table 03: North America Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022-2028, By mode of administration

Table 04: North America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 05: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Country

Table 06: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 07: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By mode of administration

Table 08: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 09: Western Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By Country

Table 10: Western Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 11: Western Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By mode of administration

Table 12: Western Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 13: Eastern Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By Country

Table 14: Eastern Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 15: Eastern Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By mode of administration

Table 16: Eastern Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 17: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis, 2013–2021 and Forecast 2022–2028, By Country

Table 18: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 19: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By mode of administration

Table 20: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 21: Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 22: Japan Vulvodynia Treatment Market size (US$ Mn)Analysis-22013–2021 and Forecast 2022–2028, By mode of administration

Table 23: Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 24: Middle East and Africa  Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Country

Table 25: Middle East and Africa  Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Drug Type

Table 26: Middle East and Africa  Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2021 and Forecast 2022–2028, By mode of administration

Table 27: Middle East and Africa  Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2021 and Forecast 2022–2028, By Distribution Channel

Table 28: Global Vulvodynia Treatment Market Size (US$ Mn) Forecast By Region, 2013-2022

Table 29: Global Vulvodynia Treatment Market Size Value (US$ Mn) Analysis 2012–2016 and Forecast 2022–2028 , By Drug Type

Table 30: Global Vulvodynia Treatment Market size (US$ Mn) Analysis 2022–2028 and Forecast 2021–2027, By Animal Type

Table 31: Global Vulvodynia Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2022–2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Pain Description by Vulvodynia Patient

Figure 02: Pain Location in Vulvodynia Patient

Figure 03: Additional Conditions Suffered By Vulvodynia Patient

Figure 04: Vulvodynia Treatment Market Split By Country (2021)

Figure 05: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 06: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 07: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 08: North America Vulvodynia Treatment Market Size Analysis, 2013–2021

Figure 09: North America Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2022–2028

Figure 10: U.S. Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 11: U.S. Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 12: Canada Vulvodynia Treatment, Market Size (US$ Mn) Analysis, 2013–2021

Figure 13: Canada Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 14: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 15: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 16: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 17: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 18: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 19: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 20: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 21: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 22: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 23: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 24: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 25: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 26: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 27: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 28: North America Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 29: North America Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022-2028 

Figure 30: North America Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022-2028

Figure 31: North America Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028  

Figure 32: Vulvodynia Treatment Market Split By Country (2021)

Figure 33: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 34: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 35: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 36: Latin America Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 37: Latin America Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2022-2028 

Figure 38: Brazil Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 39: Brazil Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 40: Mexico Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 41: Mexico Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 42: Rest of Latin America Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 43: Rest of Latin America Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 44: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 45: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 46: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 47: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 48: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 49: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 50: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2021

Figure 51: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 52: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 53: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 54: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2021

Figure 55: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 56: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 57: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028 

Figure 58: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022-2028 

Figure 59: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022-2028 

Figure 60: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022-2028 

Figure 61: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028  

Figure 62: Vulvodynia Treatment Market Split By Country (2021)

Figure 63: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 64: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 65: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 66: Western Europe Vulvodynia Treatment Market Size Analysis, 2013–2021

Figure 67: Western Europe Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2022–2028

Figure 68: U.K. Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 69: U.K. Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 70: Germany Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 71: Germany Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 72: France Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 73: France Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 74: Spain Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 75: Spain Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 76: Italy Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 77: Italy Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 78: Rest of Western Europe Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2021

Figure 79: Rest of Western Europe Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 80: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 81: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 82: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 83: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 84: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 85: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 86: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2021

Figure 87: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 88: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 89: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 90: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2021

Figure 91: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 92: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 93: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 94: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022–2028 

Figure 95: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022–2028 

Figure 96: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022–2028 

Figure 97: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 98: Vulvodynia Treatment Market Split By Country (2021)

Figure 99: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 100: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 101: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 102: Eastern Europe Vulvodynia Treatment Market Size Analysis, 2013–2021

Figure 103: Eastern Europe Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2022–2028

Figure 104: Russia Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 105: Russia Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 106: Poland Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 107: Poland Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 108: Rest of Eastern Europe Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 109: Rest of Eastern Europe Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 110: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 111: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 112: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 113: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 114: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 115: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 116: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 117: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 118: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 119: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 120: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 121: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 122: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 123: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2022–2028

Figure 124: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022–2028 

Figure 125: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022–2028 

Figure 126: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022–2028 

Figure 127: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 128: Vulvodynia Treatment Market Split By Country (2021)

Figure 129: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 130: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 131: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 132: Asia Pacific Excluding Japan Vulvodynia Treatment Market Size Analysis (US$ Mn), 2013–2021

Figure 133: Asia Pacific Excluding Japan Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y growth (%), 2022–2028

Figure 134: China Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 135: China Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 136: India Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 137: India Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 138: Australia and New Zealand Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 139: Australia and New Zealand Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 140: Rest of APEJ Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 141: Rest of APEJ Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 142: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 143: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 144: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 145: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 146: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 147: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 148: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 149: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 150: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 151: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 152: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 153: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 154: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 155: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 156: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022–2028 

Figure 157: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022–2028 

Figure 158: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022–2028 

Figure 159: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 160: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 161: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 162: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 163: Japan Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 164: Japan Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y growth, 2022–2028

Figure 165: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 166: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 167: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 168: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 169: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 170: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 171: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 172: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 173: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 174: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 175: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 176: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 177: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 178: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 179: Japan Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022–2028 

Figure 180: Japan Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022–2028 

Figure 181: Japan Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 182: Vulvodynia Treatment Market Split By Country (2021)

Figure 183: Vulvodynia Treatment Market Split By Drug Class (2021)

Figure 184: Vulvodynia Treatment Market Split By Mode of Administration (2021)

Figure 185: Vulvodynia Treatment Market Split By Distribution Channel (2021)

Figure 186: Middle East and Africa  Vulvodynia Treatment Market Size Analysis, 2013–2021

Figure 187: Middle East and Africa  Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y growth, 2022–2028

Figure 188: GCC Countries Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 189: GCC Countries Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 190: South Africa Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 191: South Africa Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 192: Rest of MEA Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 193: Rest of MEA Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 194: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 195: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 196: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 197: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 198: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 199: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 200: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 201: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 202: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 203: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 204: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 205: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 206: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 207: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 208: Middle East and Africa  Vulvodynia Treatment Market Attractiveness Analysis By Country, 2022–2028 

Figure 209: Middle East and Africa  Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2022–2028 

Figure 210: Middle East and Africa  Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2022–2028 

Figure 211: Middle East and Africa  Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 212: Global Vulvodynia Treatment Market Attractiveness Analysis By Region, 2022–2028 

Figure 213: Global Vulvodynia Treatment Market Attractiveness Analysis By Drug Type, 2022–2028 

Figure 214: Global Vulvodynia Treatment Market Attractiveness Analysis By Animal Type, 2022–2028

Figure 215: Global Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2022–2028 

Figure 216: Global Vulvodynia Treatment Market Value Analysis and Forecast, 2021–2028 (US$ Mn

Figure 217: Global Vulvodynia Treatment Market Absolute $ Opportunity (US$ Mn), 2021–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Prurigo Nodularis Treatment Market

Published : February 2021

Healthcare

Oral Solid Dosage Pharmaceutical Formulation Market

Published : July 2017

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Vulvodynia Treatment Market